DRUG BINDING INTERFACES MAPPED TO '2oip'

List of Binding Interfaces
(Click on the entry ID to view details of interfaces and pattern clusters)
(Note that ASSAM search use only 3-12 residue containing patterns)

Filter list by:

DrReposER ID	PDB	Ligand	Organism	Macromolecule	Pfam	Res.	Interface	HETATM
2OIP_A_MTXA605	2oip	MTX DB00563 (Methotrexate)	Cryptosporidium hominis	CHAIN A, CRYSTAL STRUCTURE OF DHFR	PF00186 (DHFR_1) PF00303 (Thymidylat_synt)	14	VAL A 9 ALA A 11 LEU A 25 ASP A 32 LEU A 33 LYS A 34 PHE A 36 SER A 37 THR A 58 ILE A 62 LEU A 67 ARG A 70 TYR A 119 THR A 134	MTX A 605
2OIP_B_MTXB609	2oip	MTX DB00563 (Methotrexate)	Cryptosporidium hominis	CHAIN A, CRYSTAL STRUCTURE OF DHFR	no annotation	14	VAL B 9 ALA B 11 LEU B 25 ASP B 32 LEU B 33 LYS B 34 PHE B 36 SER B 37 THR B 58 ILE B 62 LEU B 67 ARG B 70 TYR B 119 THR B 134	MTX B 609
2OIP_C_MTXC613	2oip	MTX DB00563 (Methotrexate)	Cryptosporidium hominis	CHAIN A, CRYSTAL STRUCTURE OF DHFR	no annotation	12	VAL C 9 ALA C 11 LEU C 25 ASP C 32 LEU C 33 PHE C 36 SER C 37 THR C 58 LEU C 67 ARG C 70 TYR C 119 THR C 134	MTX C 613
2OIP_D_MTXD617	2oip	MTX DB00563 (Methotrexate)	Cryptosporidium hominis	CHAIN A, CRYSTAL STRUCTURE OF DHFR	no annotation	14	VAL D 9 ALA D 11 LEU D 25 ASP D 32 LEU D 33 PHE D 36 SER D 37 THR D 58 ILE D 62 LEU D 67 ARG D 70 CYS D 113 TYR D 119 THR D 134	MTX D 617
2OIP_E_MTXE621	2oip	MTX DB00563 (Methotrexate)	Cryptosporidium hominis	CHAIN A, CRYSTAL STRUCTURE OF DHFR	no annotation	14	VAL E 9 ALA E 11 LEU E 25 ASP E 32 LEU E 33 LYS E 34 PHE E 36 SER E 37 THR E 58 ILE E 62 LEU E 67 ARG E 70 TYR E 119 THR E 134	MTX E 621

[["2OIP_A_MTXA605","2oip","MTX","DB00563(Methotrexate)","Cryptosporidium hominis","CHAIN A, CRYSTAL STRUCTURE OF DHFR","PF00186(DHFR_1);PF00303(Thymidylat_synt)",14,"VAL A   9;ALA A  11;LEU A  25;ASP A  32;LEU A  33;LYS A  34;PHE A  36;SER A  37;THR A  58;ILE A  62;LEU A  67;ARG A  70;TYR A 119;THR A 134","MTX A 605\r"],["2OIP_B_MTXB609","2oip","MTX","DB00563(Methotrexate)","Cryptosporidium hominis","CHAIN A, CRYSTAL STRUCTURE OF DHFR","no annotation",14,"VAL B   9;ALA B  11;LEU B  25;ASP B  32;LEU B  33;LYS B  34;PHE B  36;SER B  37;THR B  58;ILE B  62;LEU B  67;ARG B  70;TYR B 119;THR B 134","MTX B 609\r"],["2OIP_C_MTXC613","2oip","MTX","DB00563(Methotrexate)","Cryptosporidium hominis","CHAIN A, CRYSTAL STRUCTURE OF DHFR","no annotation",12,"VAL C   9;ALA C  11;LEU C  25;ASP C  32;LEU C  33;PHE C  36;SER C  37;THR C  58;LEU C  67;ARG C  70;TYR C 119;THR C 134","MTX C 613\r"],["2OIP_D_MTXD617","2oip","MTX","DB00563(Methotrexate)","Cryptosporidium hominis","CHAIN A, CRYSTAL STRUCTURE OF DHFR","no annotation",14,"VAL D   9;ALA D  11;LEU D  25;ASP D  32;LEU D  33;PHE D  36;SER D  37;THR D  58;ILE D  62;LEU D  67;ARG D  70;CYS D 113;TYR D 119;THR D 134","MTX D 617\r"],["2OIP_E_MTXE621","2oip","MTX","DB00563(Methotrexate)","Cryptosporidium hominis","CHAIN A, CRYSTAL STRUCTURE OF DHFR","no annotation",14,"VAL E   9;ALA E  11;LEU E  25;ASP E  32;LEU E  33;LYS E  34;PHE E  36;SER E  37;THR E  58;ILE E  62;LEU E  67;ARG E  70;TYR E 119;THR E 134","MTX E 621\r"]]